MMP7
Matrilysin
Also known as: MMP7_HUMAN, MPSL1, PUMP-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09237
- Gene
- MMP7
- Ensembl
- ENSG00000137673
- Chromosome
- 11
- Canonical length
- 267 aa
- Protein class
- Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This secreted protease breaks down proteoglycans, fibronectin, elastin and casein and differs from most MMP family members in that it lacks a conserved C-terminal hemopexin domain. The enzyme is involved in wound healing, and studies in mice suggest that it regulates the activity of defensins in intestinal mucosa. The gene is part of a cluster of MMP genes on chromosome 11. This gene exhibits elevated expression levels in multiple human cancers. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
267 residues, UniProt reviewed canonical sequence.
>P09237|MMP7
1 MRLTVLCAVC LLPGSLALPL PQEAGGMSEL QWEQAQDYLK RFYLYDSETK NANSLEAKLK
61 EMQKFFGLPI TGMLNSRVIE IMQKPRCGVP DVAEYSLFPN SPKWTSKVVT YRIVSYTRDL
121 PHITVDRLVS KALNMWGKEI PLHFRKVVWG TADIMIGFAR GAHGDSYPFD GPGNTLAHAF
181 APGTGLGGDA HFDEDERWTD GSSLGINFLY AATHELGHSL GMGHSSDPNA VMYPTYGNGD
241 PQNFKLSQDD IKGIQKLYGK RSNSRKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MMP7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 479 nTPM
Expression across tissuesHPA
Tissue
- gallbladder: 479 nTPM
- salivary gland: 253 nTPM
- urinary bladder: 197 nTPM
- breast: 158 nTPM
- kidney: 134 nTPM
- endometrium: 91 nTPM
Single-cell type
- submucosal glandular cells: 2,336 nCPM
- pancreatic duct cells: 1,485 nCPM
- endometrial secretory cells: 961 nCPM
- fallopian secretory cells: 784 nCPM
- epididymal efferent duct absorptive cells: 686 nCPM
- salivary basal cells: 607 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 0.9 nTPM
- medulla oblongata: 0.1 nTPM
- white matter: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MMP7.
Disease | ImmuneIEDB
Conditions an epitope on MMP7 was assayed in.
- bile duct adenocarcinoma T cell
- intrahepatic cholangiocarcinoma T cell
- melanoma T cell
- renal carcinoma T cell
ReferencesPubMed · IEDB
Publications for MMP7 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
2011 · World J Gastroenterol · RCR 1 · 34 citations - Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
2016 · J Oral Maxillofac Surg · RCR 0.7 · 16 citations
Reference: T cellIEDB
4 publications
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.
2012 · Nat Med · RCR 15.8 · 641 citations - Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient.
2016 · J Hepatol · RCR 2 · 69 citations - Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma.
2020 · Elife · RCR 0.6 · 17 citations - Exceptional tumor-free survival of a patient with metastatic intrahepatic cholangiocarcinoma after surgery and personalized peptide vaccination: revisiting a striking case.
2025 · J Immunother Cancer
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.52
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.43
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antibacterial peptide biosynthetic process
- collagen catabolic process
- defense response to Gram-negative bacterium
- defense response to Gram-positive bacterium
- extracellular matrix disassembly
- extracellular matrix organization
- membrane protein ectodomain proteolysis
- membrane protein intracellular domain proteolysis
- positive regulation of cell migration
- proteolysis
- regulation of cell population proliferation
- response to xenobiotic stimulus
- antibacterial peptide secretion
Molecular functions
- endopeptidase activity
- metalloendopeptidase activity
- metallopeptidase activity
- serine-type endopeptidase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MMP7 as an antibody target. Whether an autoantibody or antibody against MMP7 could matter depends on whether native MMP7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MMP7 is annotated as secreted, so native MMP7 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MMP7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...